業績
木村 文子 （特任助教）
【掲載論文】
1. Iwasaki M, Piao J, Kimura A, Sato S, Inose H, Ochi H, et al. Runx2 haploinsufficiency ameliorates the development of ossification of the posterior longitudinal ligament. PLoS ONE. 2012;7(8):e43372.
2. Nishikawa K, Nakashima T, Takeda S, Isogai M, Hamada M, Kimura A, et al. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J Clin Invest. 2010;120(10):3455-65.
3. Kimura A, Inose H, Yano F, Fujita K, Ikeda T, Sato S, et al. Runx1 and Runx2 cooperate during sternal morphogenesis. Development. 2010;137(7):1159-67.
4. Suzuki D, Yamada A, Amano T, Yasuhara R, Kimura A, Sakahara M, et al. Essential mesenchymal role of small GTPase Rac1 in interdigital programmed cell death during limb development. Dev Biol. 2009;335(2):396-406.
5. Inose H, Ochi H, Kimura A, Fujita K, Xu R, Sato S, et al. A microRNA regulatory mechanism of osteoblast differentiation.
Proc Natl Acad Sci U S A. 2009;106(49):20794-9.
6. Sato S, Kimura A, Ozdemir J, Asou Y, Miyazaki M, Jinno T, et al. The distinct role of the Runx proteins in chondrocyte
differentiation and intervertebral disc degeneration: findings in murine models and in human disease. Arthritis Rheum. 2008;58 (9):2764-75.
7. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, et al. Central control of bone remodeling by neuromedin U. Nat Med. 2007;13(10):1234-40.
1. Iwasaki M, Piao J, Kimura A, Sato S, Inose H, Ochi H, et al. Runx2 haploinsufficiency ameliorates the development of ossification of the posterior longitudinal ligament. PLoS ONE. 2012;7(8):e43372.
2. Nishikawa K, Nakashima T, Takeda S, Isogai M, Hamada M, Kimura A, et al. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J Clin Invest. 2010;120(10):3455-65.
3. Kimura A, Inose H, Yano F, Fujita K, Ikeda T, Sato S, et al. Runx1 and Runx2 cooperate during sternal morphogenesis. Development. 2010;137(7):1159-67.
4. Suzuki D, Yamada A, Amano T, Yasuhara R, Kimura A, Sakahara M, et al. Essential mesenchymal role of small GTPase Rac1 in interdigital programmed cell death during limb development. Dev Biol. 2009;335(2):396-406.
5. Inose H, Ochi H, Kimura A, Fujita K, Xu R, Sato S, et al. A microRNA regulatory mechanism of osteoblast differentiation.
Proc Natl Acad Sci U S A. 2009;106(49):20794-9.
6. Sato S, Kimura A, Ozdemir J, Asou Y, Miyazaki M, Jinno T, et al. The distinct role of the Runx proteins in chondrocyte
differentiation and intervertebral disc degeneration: findings in murine models and in human disease. Arthritis Rheum. 2008;58 (9):2764-75.
7. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, et al. Central control of bone remodeling by neuromedin U. Nat Med. 2007;13(10):1234-40.
小林 起穂 （特任助教）
【掲載論文】
1. 谷本起穂：繊維芽細胞増殖因子受容体(FGFR)2のApert型変異(S252W)による骨芽細胞の分化および石灰化の亢進．四国歯誌16 (1), 237-261 (2003)
2. Tanimoto Y, Yokozeki M, Kenji H, Matsumoto K, Nakanishi H, Matsumoto T, Marie PJ and Moriyama K: A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation In Apert syndrome. J Biol Chem 279(44), 45926-45934 (2004)
3. 谷本起穂：繊維芽細胞増殖因子受容体の変異と骨系統疾患．四国歯誌18(2)，187-193（2006）
4. 松本和也、中西秀樹、高瀬真記、古泉佳男、谷本起穂、森山啓司：トリチャーコリンズ症候群に対する下顎骨延長の中期成績. 形成外科49(3), 311-317 (2006)
5. Kinouchi N, Ohsawa Y, Ishimaru N, Ohuchi H, Sunada Y, Hayashi Y, Tanimoto Y, Moriyama K, Noji S: Atelocollagen-
mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene Ther. 15(15), 1126-30 (2008)
6. Miraoui H, Oudina K, Petite H, Tanimoto Y, Moriyama K, Marie PJ: Fibroblast growth factor receptor 2 promotes osteogenic
differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J Biol Chem. 284(8), 4897-904 (2008 )
7. Rice DP, Connor EC, Veltmaat JM, Lana-Elola E, Veistinen L, Tanimoto Y, Bellusci S, Rice R.: Gli3Xt-J/Xt-J mice exhibit lambdoid suture craniosynostosis which results from altered osteoprogenitor proliferation and differentiation. Hum Mol Genet.19(17):3457-67(2010)
8. Veistinen L, Takatalo M, Tanimoto Y, Kesper DA, Vortkamp A, Rice DP:Loss-of-Function of Gli3 in Mice Causes Abnormal Frontal Bone Morphology and Premature Synostosis of the Interfrontal Suture. Front Physiol. 3, 121(2012)
9. Tanimoto Y, Veistinen L, Alakurtti K, Takatalo M, Rice DP: Prevention of premature fusion of calvarial suture in GLI-Kruppel family member 3 (Gli3)-deficient mice by removing one allele of Runt-related transcription factor 2 (Runx2). J Biol Chem. 287 (25), 21429-38 (2012)
【著 書】
1. Yokozeki M, Tanimoto Y, Matsumoto K, Nakanishi H, Hiura K and Moriyama K: Craniofacial and dental manifestations in an Apert syndrome patient: Participation of osteoblastic cells in phenotypic expression of craniosynostosis syndrome. Orthodontics in the 21st Century, Osaka, Osaka University Press, 151-155 (2002)
【総 説】
1. 森山啓司，谷本起穂 : 繊維芽細胞増殖因子受容体2(FGFR2) 生体の科学 56, 416-417 (2005)
【症例報告】
1. Matsumoto K, Nakanishi H, Koizumi Y, Seike T, Tanimoto Y, Yokozeki M, Moriyama K, Minami M, Urano Y and Hirabayashi S:Correction of a deformed thumb by distraction of the phalanx. Scand J Plast Reconstr Surg Hand Surg 36, 368-372 (2002)
【受 賞】
1. 2003年6月, Travel grant award (1st Joint Meeting of the International Bone and Mineral Society (IBMS) and Japan Bone and Mineral Society. (15th Conference of the IBMS,)
2. 2004年12月 若野医学賞（徳島大学）
3. The JOS Young Investigatiors Award 2005 (2005年7月26日 日本矯正歯科学会学術奨励賞) 受賞対象論文: A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation In Apert syndrome. J Biol Chem 279(44), (2004)
4. 2011年10月 第70回日本矯正歯科学会大会 優秀ポスター賞
1. 谷本起穂：繊維芽細胞増殖因子受容体(FGFR)2のApert型変異(S252W)による骨芽細胞の分化および石灰化の亢進．四国歯誌16 (1), 237-261 (2003)
2. Tanimoto Y, Yokozeki M, Kenji H, Matsumoto K, Nakanishi H, Matsumoto T, Marie PJ and Moriyama K: A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation In Apert syndrome. J Biol Chem 279(44), 45926-45934 (2004)
3. 谷本起穂：繊維芽細胞増殖因子受容体の変異と骨系統疾患．四国歯誌18(2)，187-193（2006）
4. 松本和也、中西秀樹、高瀬真記、古泉佳男、谷本起穂、森山啓司：トリチャーコリンズ症候群に対する下顎骨延長の中期成績. 形成外科49(3), 311-317 (2006)
5. Kinouchi N, Ohsawa Y, Ishimaru N, Ohuchi H, Sunada Y, Hayashi Y, Tanimoto Y, Moriyama K, Noji S: Atelocollagen-
mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene Ther. 15(15), 1126-30 (2008)
6. Miraoui H, Oudina K, Petite H, Tanimoto Y, Moriyama K, Marie PJ: Fibroblast growth factor receptor 2 promotes osteogenic
differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J Biol Chem. 284(8), 4897-904 (2008 )
7. Rice DP, Connor EC, Veltmaat JM, Lana-Elola E, Veistinen L, Tanimoto Y, Bellusci S, Rice R.: Gli3Xt-J/Xt-J mice exhibit lambdoid suture craniosynostosis which results from altered osteoprogenitor proliferation and differentiation. Hum Mol Genet.19(17):3457-67(2010)
8. Veistinen L, Takatalo M, Tanimoto Y, Kesper DA, Vortkamp A, Rice DP:Loss-of-Function of Gli3 in Mice Causes Abnormal Frontal Bone Morphology and Premature Synostosis of the Interfrontal Suture. Front Physiol. 3, 121(2012)
9. Tanimoto Y, Veistinen L, Alakurtti K, Takatalo M, Rice DP: Prevention of premature fusion of calvarial suture in GLI-Kruppel family member 3 (Gli3)-deficient mice by removing one allele of Runt-related transcription factor 2 (Runx2). J Biol Chem. 287 (25), 21429-38 (2012)
【著 書】
1. Yokozeki M, Tanimoto Y, Matsumoto K, Nakanishi H, Hiura K and Moriyama K: Craniofacial and dental manifestations in an Apert syndrome patient: Participation of osteoblastic cells in phenotypic expression of craniosynostosis syndrome. Orthodontics in the 21st Century, Osaka, Osaka University Press, 151-155 (2002)
【総 説】
1. 森山啓司，谷本起穂 : 繊維芽細胞増殖因子受容体2(FGFR2) 生体の科学 56, 416-417 (2005)
【症例報告】
1. Matsumoto K, Nakanishi H, Koizumi Y, Seike T, Tanimoto Y, Yokozeki M, Moriyama K, Minami M, Urano Y and Hirabayashi S:Correction of a deformed thumb by distraction of the phalanx. Scand J Plast Reconstr Surg Hand Surg 36, 368-372 (2002)
【受 賞】
1. 2003年6月, Travel grant award (1st Joint Meeting of the International Bone and Mineral Society (IBMS) and Japan Bone and Mineral Society. (15th Conference of the IBMS,)
2. 2004年12月 若野医学賞（徳島大学）
3. The JOS Young Investigatiors Award 2005 (2005年7月26日 日本矯正歯科学会学術奨励賞) 受賞対象論文: A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation In Apert syndrome. J Biol Chem 279(44), (2004)
4. 2011年10月 第70回日本矯正歯科学会大会 優秀ポスター賞
林 深 （特任講師）
【掲載論文】
1. Takanashi J, Okamoto N, Yamamoto Y, Hayashi S, Arai H, Takahashi Y, Maruyama K, Mizuno S, Shimakawa S, Ono H, Oyanagi R, Kubo S, Barkovich AJ, Inazawa J.: Clinical and radiological features of Japanese patients with a severe
phenotype due to CASK mutations. Am J Med Genet A. 158A:3112-8, 2012.
2. Honda S, Hayashi S, Nakane T, Imoto I, Kurosawa K, Mizuno S, Okamoto N, Kato M, Kubota T, Nakagawa E, Goto Y, Inazawa J.: The incidence of hypoplasia of the corpus callosum in patients with dup(X)(q28) involving MECP2 is associated with the location of distal breakpoints. Am J Med Genet A. 158A:1292-303, 2012.
3. Okamoto N, Hayashi S, Masui A, Kosaki R, Oguri I, Hasegawa T, Imoto I, Makita Y, Hata A, Moriyama K, Inazawa J.: Deletion at chromosome 10p11.23-p12.1 defines characteristic phenotypes with marked midfacial hypoplasia. J Hum Genet. 57:191-6, 2012.
4. Maeda MH, Mitsui J, Soong BW, Takahashi Y, Ishiura H, Hayashi S, Shirota Y, Ichikawa Y, Matsumoto H, Arai M, Okamoto T, Miyama S, Shimizu J, Inazawa J, Goto J, Tsuji S.: Increased gene dosage of myelin protein zero causes Charcot-Marie- Tooth disease. Ann Neurol. 71:84-92, 2012
5. Honda S, Satomura S, Hayashi S, Imoto I, Nakagawa E, Goto Y, Inazawa J, Japanese Mental Retardation Consortium.: Concomitant microduplications of MECP2 and ATRX in male patients with severe mental retardation. J Hum Genet. 57:73-7, 2012.
6. Hayashi S, Okamoto N, Chinen Y, Takanashi J, Makita Y, Hata A, Imoto I, Inazawa J.: Novel intragenic duplications and mutations of CASK in patients with mental retardation and microcephaly with pontine and cerebellar hypoplasia (MICPCH). Hum Genet. 131:99-110, 2012.
7. Hayashi S, Imoto I, Aizu Y, Okamoto N, Mizuno S, Kurosawa K, Okamoto N, Honda S, Araki S, Mizutani S, Numabe H, Saitoh S, Kosho T, Fukushima Y, Mitsubuchi H, Endo F, Chinen Y, Kosaki R, Okuyama T, Ohki H, Yoshihashi H, Ono M, Takada F, Ono H, Yagi M, Matsumoto H, Makita Y, Hata A, Inazawa J.: Clinical application of Array-based Comparative Genomic Hybridization by Two-stage Screening for 536 Patients with Mental Retardation and Multiple Congenital Anomalies.
J Hum Genet. 56:110-24, 2011.
8. Takanashi J, Arai H, Nabatame S, Hirai S, Hayashi S, Inazawa J, Okamoto N, Barkovich AJ.: Neuroradiologic Features of CASK Mutations. AJNR Am J Neuroradiol. 31: 1619-22, 2010.
9. Honda S, Hayashi S, Imoto I, Toyama J, Okazawa H, Nakagawa E, Goto Y, Inazawa J, Japanese Mental Retardation Consortium.: Copy-number variations on the X chromosome in Japanese patients with mental retardation detected by array-
based comparative genomic hybridization analysis. J Hum Genet. 55: 590-9, 2010.
10. Honda S, Orii KO, Kobayashi J, Hayashi S, Imamura A, Imoto I, Nakagawa E, Goto Y, Inazawa J.: Novel deletion at Xq24
including the UBE2A gene in a patient with X-linked mental retardation. J Hum Genet. 55: 244-7, 2010.
11. Hayashi S, Okamoto N, Makita Y, Hata A, Imoto I, Inazawa J.: Heterozygous deletion at 14q22.1-q22.3 including the BMP4 gene in a patient with psychomotor retardation, congenital corneal opacity and feet polysyndactyly. Am J Med Genet A. 146: 2905-10, 2008.
12. Hayashi S, Mizuno S, Migita O, Okuyama T, Makita Y, Hata A, Imoto I, Inazawa J.: The CASK gene harbored in a deletion detected by array-CGH as a potential candidate for a gene causative of X-linked dominant mental retardation. Am J Med Genet A. 146 :2145-51, 2008.
13. Arai A, Yan W, Wakabayashi S, Hayashi S, Inazawa J, Miura O.: Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe hepatotoxicity. Int J Hematol. 86: 233-7, 2007
14. Okamoto N, Kubota T, Nakamura Y, Murakami R, Nishikubo T, Tanaka I, Takahashi Y, Hayashi S, Imoto I, Inazawa J, Hosokai N, Kohsaka S, Uchino S.: 22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome? Am J Med Genet A. 143: 2804-9, 2007.
15. Udaka T, Imoto I, Aizu Y, Torii C, Izumi K, Kosaki R, Takahashi T, Hayashi S, Inazawa J, Kosaki K.: Multiplex PCR/liquid chromatography assay for screening of subtelomeric rearrangements. Genet Test. 11: 241-8, 2007.
16. Chiyonobu T, Hayashi S, Kobayashi K, Morimoto M, Miyanomae Y, Nishimura A, Nishimoto A, Ito C, Imoto I, Sugimoto T, Jia Z, Inazawa J, Toda T. Partial tandem duplication of GRIA3 in a male with mental retardation. Am J Med Genet A. 143: 1448-55, 2007.
17. Tokutomi T, Hayashi S, Imai K, Chida A, Ishiwata T, Asano Y, Inazawa J, Nonoyama S: Dup(8p)/del(8q) Recombinant Chromosome in a Girl With Hepatic Focal Nodular Hyperplasia. Am J Med Genet A. 143: 1334-7, 2007.
18. Hayashi S, Ono M, Makita Y, Imoto I, Mizutani S, Inazawa J.: Fortuitous Detection of a Submicroscopic Deletion at 1q25 in a Girl With Cornelia-de Lange Syndrome Carrying t(5;13)(p13.1;q12.1) by Array-based Comparative Genomic Hybridization. Am J Med Genet A. 143: 1191-7, 2007.
19. Hayashi S, Honda S, Minaguchi M, Makita Y, Okamoto N, Kosaki R, Okuyama T, Imoto I, Mizutani S, Inazawa J.: Construction of a high-density and high-resolution human chromosome X array for comparative genomic hybridization analysis. J Hum Genet. 52: 397-405, 2007.
20. Honda S, Hayashi S, Kato M, Niida Y, Hayasaka K, Okuyama T, Imoto I, Mizutani S, Inazawa J.: Clinical and molecular cytogenetic characterization of two patients with non-mutational aberrations of the FMR2 gene. Am J Med Genet A. 143: 687- 93, 2007.
21. Nishioka K, Hayashi S, Farrer MJ, Singleton AB, Yoshino H, Imai H, Kitami T, Sato K, Kuroda R, Tomiyama H, Mizoguchi K, Murata M, Toda T, Imoto I, Inazawa J, Mizuno Y, Hattori N.: Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann Neurol. 59: 298-309, 2006.
22. Hayashi S, Kurosawa K, Imoto I, Mizutani S, Inazawa J.: Detection of cryptic chromosome aberrations in a patient with a balanced t(1;9)(p34.2;p24) by array-based comparative genomic hybridization. Am J Med Genet A. 139: 32-36, 2005.
【著 書】
1. 稲澤譲治，林深，井本逸勢：診断への応用．51-57. 林深，稲澤讓治：他．稲澤譲治，蒔田芳男，羽田明 編：アレイCGH診断活用ガイドブック．医薬ジャーナル社，東京．2008.
【総 説】
1. 林深，稲澤讓治，蒔田芳男：アレイCGHを用いた先天異常疾患の網羅的ゲノム異常解析と疾患原因遺伝子の探索．金原出版株式会社，小児科．52: 1583-1590, 2011.
2. 林深，稲澤讓治：アレイCGHによる先天異常の解析．金原出版株式会社，小児科．50: 847-853, 2009.
3. 林深，井本逸勢，稲澤譲治：ゲノム微細構造異常と先天異常疾患．診断と治療社，小児科診療．72: 31-37, 2009.
4. 林深，井本逸勢，稲澤譲治：アレイCGHによる先天異常症の潜在的染色体異常診断と解析．医歯薬出版株式会社，医学のあゆみ．225: 845-849, 2008.
5. 林深，稲澤譲治：BACアレイを用いた微細染色体異常の検出．東京医学社，小児内科．37: 1399-1404, 2005.
【受 賞】
1. 平成24年 3月 難治疾患研究所若手研究者発表会 第１位
2. 平成18年 6月 東京医科歯科大学小児科同窓会賞
1. Takanashi J, Okamoto N, Yamamoto Y, Hayashi S, Arai H, Takahashi Y, Maruyama K, Mizuno S, Shimakawa S, Ono H, Oyanagi R, Kubo S, Barkovich AJ, Inazawa J.: Clinical and radiological features of Japanese patients with a severe
phenotype due to CASK mutations. Am J Med Genet A. 158A:3112-8, 2012.
2. Honda S, Hayashi S, Nakane T, Imoto I, Kurosawa K, Mizuno S, Okamoto N, Kato M, Kubota T, Nakagawa E, Goto Y, Inazawa J.: The incidence of hypoplasia of the corpus callosum in patients with dup(X)(q28) involving MECP2 is associated with the location of distal breakpoints. Am J Med Genet A. 158A:1292-303, 2012.
3. Okamoto N, Hayashi S, Masui A, Kosaki R, Oguri I, Hasegawa T, Imoto I, Makita Y, Hata A, Moriyama K, Inazawa J.: Deletion at chromosome 10p11.23-p12.1 defines characteristic phenotypes with marked midfacial hypoplasia. J Hum Genet. 57:191-6, 2012.
4. Maeda MH, Mitsui J, Soong BW, Takahashi Y, Ishiura H, Hayashi S, Shirota Y, Ichikawa Y, Matsumoto H, Arai M, Okamoto T, Miyama S, Shimizu J, Inazawa J, Goto J, Tsuji S.: Increased gene dosage of myelin protein zero causes Charcot-Marie- Tooth disease. Ann Neurol. 71:84-92, 2012
5. Honda S, Satomura S, Hayashi S, Imoto I, Nakagawa E, Goto Y, Inazawa J, Japanese Mental Retardation Consortium.: Concomitant microduplications of MECP2 and ATRX in male patients with severe mental retardation. J Hum Genet. 57:73-7, 2012.
6. Hayashi S, Okamoto N, Chinen Y, Takanashi J, Makita Y, Hata A, Imoto I, Inazawa J.: Novel intragenic duplications and mutations of CASK in patients with mental retardation and microcephaly with pontine and cerebellar hypoplasia (MICPCH). Hum Genet. 131:99-110, 2012.
7. Hayashi S, Imoto I, Aizu Y, Okamoto N, Mizuno S, Kurosawa K, Okamoto N, Honda S, Araki S, Mizutani S, Numabe H, Saitoh S, Kosho T, Fukushima Y, Mitsubuchi H, Endo F, Chinen Y, Kosaki R, Okuyama T, Ohki H, Yoshihashi H, Ono M, Takada F, Ono H, Yagi M, Matsumoto H, Makita Y, Hata A, Inazawa J.: Clinical application of Array-based Comparative Genomic Hybridization by Two-stage Screening for 536 Patients with Mental Retardation and Multiple Congenital Anomalies.
J Hum Genet. 56:110-24, 2011.
8. Takanashi J, Arai H, Nabatame S, Hirai S, Hayashi S, Inazawa J, Okamoto N, Barkovich AJ.: Neuroradiologic Features of CASK Mutations. AJNR Am J Neuroradiol. 31: 1619-22, 2010.
9. Honda S, Hayashi S, Imoto I, Toyama J, Okazawa H, Nakagawa E, Goto Y, Inazawa J, Japanese Mental Retardation Consortium.: Copy-number variations on the X chromosome in Japanese patients with mental retardation detected by array-
based comparative genomic hybridization analysis. J Hum Genet. 55: 590-9, 2010.
10. Honda S, Orii KO, Kobayashi J, Hayashi S, Imamura A, Imoto I, Nakagawa E, Goto Y, Inazawa J.: Novel deletion at Xq24
including the UBE2A gene in a patient with X-linked mental retardation. J Hum Genet. 55: 244-7, 2010.
11. Hayashi S, Okamoto N, Makita Y, Hata A, Imoto I, Inazawa J.: Heterozygous deletion at 14q22.1-q22.3 including the BMP4 gene in a patient with psychomotor retardation, congenital corneal opacity and feet polysyndactyly. Am J Med Genet A. 146: 2905-10, 2008.
12. Hayashi S, Mizuno S, Migita O, Okuyama T, Makita Y, Hata A, Imoto I, Inazawa J.: The CASK gene harbored in a deletion detected by array-CGH as a potential candidate for a gene causative of X-linked dominant mental retardation. Am J Med Genet A. 146 :2145-51, 2008.
13. Arai A, Yan W, Wakabayashi S, Hayashi S, Inazawa J, Miura O.: Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe hepatotoxicity. Int J Hematol. 86: 233-7, 2007
14. Okamoto N, Kubota T, Nakamura Y, Murakami R, Nishikubo T, Tanaka I, Takahashi Y, Hayashi S, Imoto I, Inazawa J, Hosokai N, Kohsaka S, Uchino S.: 22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome? Am J Med Genet A. 143: 2804-9, 2007.
15. Udaka T, Imoto I, Aizu Y, Torii C, Izumi K, Kosaki R, Takahashi T, Hayashi S, Inazawa J, Kosaki K.: Multiplex PCR/liquid chromatography assay for screening of subtelomeric rearrangements. Genet Test. 11: 241-8, 2007.
16. Chiyonobu T, Hayashi S, Kobayashi K, Morimoto M, Miyanomae Y, Nishimura A, Nishimoto A, Ito C, Imoto I, Sugimoto T, Jia Z, Inazawa J, Toda T. Partial tandem duplication of GRIA3 in a male with mental retardation. Am J Med Genet A. 143: 1448-55, 2007.
17. Tokutomi T, Hayashi S, Imai K, Chida A, Ishiwata T, Asano Y, Inazawa J, Nonoyama S: Dup(8p)/del(8q) Recombinant Chromosome in a Girl With Hepatic Focal Nodular Hyperplasia. Am J Med Genet A. 143: 1334-7, 2007.
18. Hayashi S, Ono M, Makita Y, Imoto I, Mizutani S, Inazawa J.: Fortuitous Detection of a Submicroscopic Deletion at 1q25 in a Girl With Cornelia-de Lange Syndrome Carrying t(5;13)(p13.1;q12.1) by Array-based Comparative Genomic Hybridization. Am J Med Genet A. 143: 1191-7, 2007.
19. Hayashi S, Honda S, Minaguchi M, Makita Y, Okamoto N, Kosaki R, Okuyama T, Imoto I, Mizutani S, Inazawa J.: Construction of a high-density and high-resolution human chromosome X array for comparative genomic hybridization analysis. J Hum Genet. 52: 397-405, 2007.
20. Honda S, Hayashi S, Kato M, Niida Y, Hayasaka K, Okuyama T, Imoto I, Mizutani S, Inazawa J.: Clinical and molecular cytogenetic characterization of two patients with non-mutational aberrations of the FMR2 gene. Am J Med Genet A. 143: 687- 93, 2007.
21. Nishioka K, Hayashi S, Farrer MJ, Singleton AB, Yoshino H, Imai H, Kitami T, Sato K, Kuroda R, Tomiyama H, Mizoguchi K, Murata M, Toda T, Imoto I, Inazawa J, Mizuno Y, Hattori N.: Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann Neurol. 59: 298-309, 2006.
22. Hayashi S, Kurosawa K, Imoto I, Mizutani S, Inazawa J.: Detection of cryptic chromosome aberrations in a patient with a balanced t(1;9)(p34.2;p24) by array-based comparative genomic hybridization. Am J Med Genet A. 139: 32-36, 2005.
【著 書】
1. 稲澤譲治，林深，井本逸勢：診断への応用．51-57. 林深，稲澤讓治：他．稲澤譲治，蒔田芳男，羽田明 編：アレイCGH診断活用ガイドブック．医薬ジャーナル社，東京．2008.
【総 説】
1. 林深，稲澤讓治，蒔田芳男：アレイCGHを用いた先天異常疾患の網羅的ゲノム異常解析と疾患原因遺伝子の探索．金原出版株式会社，小児科．52: 1583-1590, 2011.
2. 林深，稲澤讓治：アレイCGHによる先天異常の解析．金原出版株式会社，小児科．50: 847-853, 2009.
3. 林深，井本逸勢，稲澤譲治：ゲノム微細構造異常と先天異常疾患．診断と治療社，小児科診療．72: 31-37, 2009.
4. 林深，井本逸勢，稲澤譲治：アレイCGHによる先天異常症の潜在的染色体異常診断と解析．医歯薬出版株式会社，医学のあゆみ．225: 845-849, 2008.
5. 林深，稲澤譲治：BACアレイを用いた微細染色体異常の検出．東京医学社，小児内科．37: 1399-1404, 2005.
【受 賞】
1. 平成24年 3月 難治疾患研究所若手研究者発表会 第１位
2. 平成18年 6月 東京医科歯科大学小児科同窓会賞
森田 圭一 （特任講師）
【掲載論文】
1. Kugimoto T, Morita K, Omura K. Development of oral cancer screening test by detection of squamous cell carcinoma among exfoliated oral mucosal cells. Oral Oncol. 2012 Sep;48(9):794-798.
2. Kuribayashi Y, Tsushima F, Sato M, Morita K, Omura K. Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy. J Oral Pathol Med. 2012 Oct;41(9):682-688.
3. Sakamoto K, Fujii T, Kawachi H, Miki Y, Omura K, Morita K, Kayamori K, Katsube K, Yamaguchi A. Reduction of NOTCH1 expression pertains to maturation abnormalities of keratinocytes in squamous neoplasms. Lab Invest. 2012 May;92(5):688-702.
4. Hanabata Y, Nakajima Y, Morita K, Kayamori K, Omura K. Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma. Odontology. 2012 Jul;100(2):156-163.
5. Khanom R, Sakamoto K, Pal SK, Shimada Y, Morita K, Omura K, Miki Y, Yamaguchi A. Expression of basal cell keratin 15 and keratin 19 in oral squamous neoplasms represents diverse pathophysiologies. Histol Histopathol. 2012 Jul;27(7):949-959.
6. Shimada Y, Morita KI, Kabasawa Y, Taguchi T, Omura K. Clinical manifestations and treatment for keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome: a study in 25 Japanese patients. J Oral Pathol Med. 2012 Aug 8;
7. Matsumoto K, Morita KI, Jinno S, Omura K. Sensory changes after tongue reduction for macroglossia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Aug 15;
8. Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res. 2011 Sep 1;71(17):5765-5778.
9. Sakamoto K, Aragaki T, Morita K, Kawachi H, Kayamori K, Nakanishi S, Omura K, Miki Y, Okada N, Katsube K, Takizawa T, Yamaguchi A. Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis. Histopathology. 2011 Mar;58(4):531-542.
10. Marukawa E, Oshina H, Iino G, Morita K, Omura K. Reduction of bone resorption by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar cleft. J Craniomaxillofac Surg. 2011 Jun;39(4):278-283.
11. Kayamori K, Sakamoto K, Nakashima T, Takayanagi H, Morita K, Omura K, Nguyen ST, Miki Y, Iimura T, Himeno A, Akashi T, Yamada-Okabe H, Ogata E, Yamaguchi A. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. Am J Pathol. 2010 Feb;176(2):968-980.
12. Prapinjumrune C, Morita K, Kuribayashi Y, Hanabata Y, Shi Q, Nakajima Y, Inazawa J, Omura K. DNA amplification and expression of FADD in oral squamous cell carcinoma. J Oral Pathol Med. 2010 Aug 1;39(7):525-532.
13. Uekusa M, Omura K, Nakajima Y, Hasegawa S, Harada H, Morita KI, Tsuda H. Uptake and kinetics of 5-aminolevulinic acid in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2010 Aug;39(8):802-805.
14. Kuribayashi Y, Morita K, Tomioka H, Uekusa M, Ito D, Omura K. Gene expression analysis by oligonucleotide microarray in oral leukoplakia. J Oral Pathol Med. 2009 Apr;38(4):356-361.
15. Morita K, Iwasa T, Imaizumi F, Negishi A, Omura K. A case of maxillary duplication with a soft palate reconstruction using a forearm flap. Int J Oral Maxillofac Surg. 2008 Sep;37(9):862-865.
16. Tomioka H, Morita K, Hasegawa S, Omura K. Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med. 2006 Apr;35(4):206-211.
17. Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H, Ichijo H. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 2001 Nov 1;20(21):6028-6036.
18. Sawada Y, Nakamura K, Doi K, Takeda K, Tobiume K, Saitoh M, Morita K, Komuro I, De Vos K, Sheetz M, Ichijo H. Rap1 is involved in cell stretching modulation of p38 but not ERK or JNK MAP kinase. J Cell Sci. 2001 Mar;114(Pt 6):1221-1227.
19. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2001 Mar;2(3):222-228.
【掲載論文（和文）】
1. 田口 貴英, 森田 圭一, 島田 泰如, 小村 健. 角化嚢胞性歯原性腫瘍再発に関する臨床的検討. 日本口腔腫瘍学会誌. 2012;24(1):9-19.
2. 菊池 剛, 森田 圭一, 樺沢 勇司, 小村 健. Le Fort I型骨切り術後に生じた皮下気腫の1例. 日本口腔外科学会雑誌. 2011;57(3):124-127.
3. 本田 綾, 馬場 祥行, 片岡 恵一, 鈴木 聖一, 森田 圭一, 小村 健, 森山 啓司. Le Fort I型骨切り術により幅の広い顎裂を閉鎖した成人片側性口唇口蓋裂の1症例. 日本顎変形症学会雑誌. 2010;20(3):258-265.
4. 森田 圭一, 菊池 剛, 今泉 史子, 根岸 綾子, 辻 美千子, 小村 健. 新規創内固定型上顎骨延長装置を用いて治療した両側唇顎口蓋裂術後上顎後退症の1例. 日本口腔外科学会雑誌. 2010;56(7):450-454.
5. 高根 努, 森田 圭一, 佐藤 昌, 樺沢 勇司, 丸岡 豊, 小村 健. Le Fort I型骨切り術後に生じたsurgical ciliated cystの1例. 日本口腔外科学会雑誌. 2008;54(11):616-620.
6. 櫻井 由美子, 馬場 祥行, 石崎 敬, 辻 美千子, 佐藤 豊, 天笠 光雄, 森田 圭一, 小村 健, 鈴木 聖一, 大山 紀美栄. 東京医科歯科大学歯学部附属病院における口唇裂口蓋裂患者の統計的調査. 日本口蓋裂学会雑誌. 2007;32(3):307-316.
7. 森田 圭一, 丸川 恵理子, 小村 健. 腸骨からの骨髄海綿骨細片採取におけるBoneHOGの使用経験. 日本口腔外科学会雑誌. 2007;53(11):682-685.
8. 生田 稔, 小村 健, 丸岡 豊, 長谷川 正午, 森田 圭一. 下顎骨関節突起骨折に関する臨床的検討. 口腔顎顔面外傷. 2006;5(1):2-7.
9. 森田 圭一, 石井 正俊, 森山 孝, 今泉 史子, 小村 健. 片側性口唇裂の外鼻修正術後における外鼻形態の後戻り評価. 日本口蓋裂学会雑誌. 2004;29(3):298-304.
10. 石井 正俊, 森山 孝, 森田 圭一, 今泉 史子, 小村 健, 石井 良昌, 大山 紀美栄, 本橋 信義, 飯田 敏明, 谷口 尚, 小野 富昭, 杉山 芳樹. 顎裂部への二次的骨移植に関する臨床的検討(第一報) 手術時期別骨架橋形成について. 日本口蓋裂学会雑誌. 2004;29(3):270-277.
11. 森田 圭一, 郡司 明美, 石井 正俊, 森山 孝, 今泉 史子, 小村 健. 術前鼻歯槽形成法による片側性完全唇顎口蓋裂患者の初期治療. 日本口腔外科学会雑誌. 2004;50(11):643-648.
12. 渡邉 洋次, 樺沢 勇司, 大倉 一徳, 森山 孝, 高橋 悦子, 生田 稔, 森田 圭一, 丸川 恵理子, 石畝 亘, 小村 健. 顎骨に生じた開花性セメント質骨異形成症の臨床病理学的検討. 日本口腔外科学会雑誌. 2003;49(5):323-328.
13. 今泉 史子, 石井 正俊, 石井 良昌, 森山 孝, 郡司 明美, 森田 圭一, 榎本 昭二, 小村 健, 壬生 美智子. 上顎骨骨切り術が鼻咽腔閉鎖機能に及ぼす影響について. 日本口蓋裂学会雑誌. 2001;26(3):325-332.
14. 佐戸 敦子, 石井 正俊, 石井 良昌, 森山 孝, 森田 圭一, 郡司 明美, 今泉 史子, 村瀬 嘉代子, 高橋 雄三, 榎本 昭二. 口唇口蓋裂患者の病名告知に関する研究. 日本口蓋裂学会雑誌. 2001;26(1):97-113.
【総 説】
1. 森田 圭一, 一條 秀憲. 酸化ストレスとアポトーシス ストレスキナーゼASK1の解析から. 臨床免疫. 2002;38(1):107-112.
2. 松沢 厚, 森田 圭一, 一條 秀憲. 【酸化ストレス フリーラジカル医学生物学の最前線】 酸化ストレスの基礎 ASK1によるストレス誘導性アポトーシスと疾患 ASK1ノックアウトマウスの解析から. 医学のあゆみ. 2001;別冊(酸化ストレスーフリーラジカル医学生物学の最前線):76-81.
3. 森田 圭一, 一條 秀憲. 【情報伝達研究の最前線】 細胞増殖・生存・アポトーシスに関する情報伝達 セリン・スレオニンキナーゼを介したアポトーシス制御機構 ストレス活性化MAPキナーゼ系による制御. 医学のあゆみ. 2000;194(5):314-318.
1. Kugimoto T, Morita K, Omura K. Development of oral cancer screening test by detection of squamous cell carcinoma among exfoliated oral mucosal cells. Oral Oncol. 2012 Sep;48(9):794-798.
2. Kuribayashi Y, Tsushima F, Sato M, Morita K, Omura K. Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy. J Oral Pathol Med. 2012 Oct;41(9):682-688.
3. Sakamoto K, Fujii T, Kawachi H, Miki Y, Omura K, Morita K, Kayamori K, Katsube K, Yamaguchi A. Reduction of NOTCH1 expression pertains to maturation abnormalities of keratinocytes in squamous neoplasms. Lab Invest. 2012 May;92(5):688-702.
4. Hanabata Y, Nakajima Y, Morita K, Kayamori K, Omura K. Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma. Odontology. 2012 Jul;100(2):156-163.
5. Khanom R, Sakamoto K, Pal SK, Shimada Y, Morita K, Omura K, Miki Y, Yamaguchi A. Expression of basal cell keratin 15 and keratin 19 in oral squamous neoplasms represents diverse pathophysiologies. Histol Histopathol. 2012 Jul;27(7):949-959.
6. Shimada Y, Morita KI, Kabasawa Y, Taguchi T, Omura K. Clinical manifestations and treatment for keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome: a study in 25 Japanese patients. J Oral Pathol Med. 2012 Aug 8;
7. Matsumoto K, Morita KI, Jinno S, Omura K. Sensory changes after tongue reduction for macroglossia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Aug 15;
8. Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res. 2011 Sep 1;71(17):5765-5778.
9. Sakamoto K, Aragaki T, Morita K, Kawachi H, Kayamori K, Nakanishi S, Omura K, Miki Y, Okada N, Katsube K, Takizawa T, Yamaguchi A. Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis. Histopathology. 2011 Mar;58(4):531-542.
10. Marukawa E, Oshina H, Iino G, Morita K, Omura K. Reduction of bone resorption by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar cleft. J Craniomaxillofac Surg. 2011 Jun;39(4):278-283.
11. Kayamori K, Sakamoto K, Nakashima T, Takayanagi H, Morita K, Omura K, Nguyen ST, Miki Y, Iimura T, Himeno A, Akashi T, Yamada-Okabe H, Ogata E, Yamaguchi A. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. Am J Pathol. 2010 Feb;176(2):968-980.
12. Prapinjumrune C, Morita K, Kuribayashi Y, Hanabata Y, Shi Q, Nakajima Y, Inazawa J, Omura K. DNA amplification and expression of FADD in oral squamous cell carcinoma. J Oral Pathol Med. 2010 Aug 1;39(7):525-532.
13. Uekusa M, Omura K, Nakajima Y, Hasegawa S, Harada H, Morita KI, Tsuda H. Uptake and kinetics of 5-aminolevulinic acid in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2010 Aug;39(8):802-805.
14. Kuribayashi Y, Morita K, Tomioka H, Uekusa M, Ito D, Omura K. Gene expression analysis by oligonucleotide microarray in oral leukoplakia. J Oral Pathol Med. 2009 Apr;38(4):356-361.
15. Morita K, Iwasa T, Imaizumi F, Negishi A, Omura K. A case of maxillary duplication with a soft palate reconstruction using a forearm flap. Int J Oral Maxillofac Surg. 2008 Sep;37(9):862-865.
16. Tomioka H, Morita K, Hasegawa S, Omura K. Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med. 2006 Apr;35(4):206-211.
17. Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H, Ichijo H. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 2001 Nov 1;20(21):6028-6036.
18. Sawada Y, Nakamura K, Doi K, Takeda K, Tobiume K, Saitoh M, Morita K, Komuro I, De Vos K, Sheetz M, Ichijo H. Rap1 is involved in cell stretching modulation of p38 but not ERK or JNK MAP kinase. J Cell Sci. 2001 Mar;114(Pt 6):1221-1227.
19. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2001 Mar;2(3):222-228.
【掲載論文（和文）】
1. 田口 貴英, 森田 圭一, 島田 泰如, 小村 健. 角化嚢胞性歯原性腫瘍再発に関する臨床的検討. 日本口腔腫瘍学会誌. 2012;24(1):9-19.
2. 菊池 剛, 森田 圭一, 樺沢 勇司, 小村 健. Le Fort I型骨切り術後に生じた皮下気腫の1例. 日本口腔外科学会雑誌. 2011;57(3):124-127.
3. 本田 綾, 馬場 祥行, 片岡 恵一, 鈴木 聖一, 森田 圭一, 小村 健, 森山 啓司. Le Fort I型骨切り術により幅の広い顎裂を閉鎖した成人片側性口唇口蓋裂の1症例. 日本顎変形症学会雑誌. 2010;20(3):258-265.
4. 森田 圭一, 菊池 剛, 今泉 史子, 根岸 綾子, 辻 美千子, 小村 健. 新規創内固定型上顎骨延長装置を用いて治療した両側唇顎口蓋裂術後上顎後退症の1例. 日本口腔外科学会雑誌. 2010;56(7):450-454.
5. 高根 努, 森田 圭一, 佐藤 昌, 樺沢 勇司, 丸岡 豊, 小村 健. Le Fort I型骨切り術後に生じたsurgical ciliated cystの1例. 日本口腔外科学会雑誌. 2008;54(11):616-620.
6. 櫻井 由美子, 馬場 祥行, 石崎 敬, 辻 美千子, 佐藤 豊, 天笠 光雄, 森田 圭一, 小村 健, 鈴木 聖一, 大山 紀美栄. 東京医科歯科大学歯学部附属病院における口唇裂口蓋裂患者の統計的調査. 日本口蓋裂学会雑誌. 2007;32(3):307-316.
7. 森田 圭一, 丸川 恵理子, 小村 健. 腸骨からの骨髄海綿骨細片採取におけるBoneHOGの使用経験. 日本口腔外科学会雑誌. 2007;53(11):682-685.
8. 生田 稔, 小村 健, 丸岡 豊, 長谷川 正午, 森田 圭一. 下顎骨関節突起骨折に関する臨床的検討. 口腔顎顔面外傷. 2006;5(1):2-7.
9. 森田 圭一, 石井 正俊, 森山 孝, 今泉 史子, 小村 健. 片側性口唇裂の外鼻修正術後における外鼻形態の後戻り評価. 日本口蓋裂学会雑誌. 2004;29(3):298-304.
10. 石井 正俊, 森山 孝, 森田 圭一, 今泉 史子, 小村 健, 石井 良昌, 大山 紀美栄, 本橋 信義, 飯田 敏明, 谷口 尚, 小野 富昭, 杉山 芳樹. 顎裂部への二次的骨移植に関する臨床的検討(第一報) 手術時期別骨架橋形成について. 日本口蓋裂学会雑誌. 2004;29(3):270-277.
11. 森田 圭一, 郡司 明美, 石井 正俊, 森山 孝, 今泉 史子, 小村 健. 術前鼻歯槽形成法による片側性完全唇顎口蓋裂患者の初期治療. 日本口腔外科学会雑誌. 2004;50(11):643-648.
12. 渡邉 洋次, 樺沢 勇司, 大倉 一徳, 森山 孝, 高橋 悦子, 生田 稔, 森田 圭一, 丸川 恵理子, 石畝 亘, 小村 健. 顎骨に生じた開花性セメント質骨異形成症の臨床病理学的検討. 日本口腔外科学会雑誌. 2003;49(5):323-328.
13. 今泉 史子, 石井 正俊, 石井 良昌, 森山 孝, 郡司 明美, 森田 圭一, 榎本 昭二, 小村 健, 壬生 美智子. 上顎骨骨切り術が鼻咽腔閉鎖機能に及ぼす影響について. 日本口蓋裂学会雑誌. 2001;26(3):325-332.
14. 佐戸 敦子, 石井 正俊, 石井 良昌, 森山 孝, 森田 圭一, 郡司 明美, 今泉 史子, 村瀬 嘉代子, 高橋 雄三, 榎本 昭二. 口唇口蓋裂患者の病名告知に関する研究. 日本口蓋裂学会雑誌. 2001;26(1):97-113.
【総 説】
1. 森田 圭一, 一條 秀憲. 酸化ストレスとアポトーシス ストレスキナーゼASK1の解析から. 臨床免疫. 2002;38(1):107-112.
2. 松沢 厚, 森田 圭一, 一條 秀憲. 【酸化ストレス フリーラジカル医学生物学の最前線】 酸化ストレスの基礎 ASK1によるストレス誘導性アポトーシスと疾患 ASK1ノックアウトマウスの解析から. 医学のあゆみ. 2001;別冊(酸化ストレスーフリーラジカル医学生物学の最前線):76-81.
3. 森田 圭一, 一條 秀憲. 【情報伝達研究の最前線】 細胞増殖・生存・アポトーシスに関する情報伝達 セリン・スレオニンキナーゼを介したアポトーシス制御機構 ストレス活性化MAPキナーゼ系による制御. 医学のあゆみ. 2000;194(5):314-318.